Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Markovic, Bojana Simovic ^a   Nikolic, Aleksandar ^a   Gazdic, Marina ^a   Nurkovic, Jasmin ^b   Djordjevic, Irena ^a   Arsenijevic, Nebojsa ^a   Stojkovic, Miodrag ^a,c   Lukic, Miodrag L ^a   Volarevic, Vladislav ^a  

^a University of Kragujevac Medical Faculty   (Serbia)

^b STATE UNIVERSITY OF NOVI PAZAR   (Serbia)

^c Spebo Medical   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

DAVANAT; DEXTRAN SULFATE; GALECTIN 3; INTERLEUKIN 10; INTERLEUKIN 1BETA; LYMPHOTOXIN; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL POPULATION; COLITIS; CONTROLLED STUDY; CYTOMETRY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHARMACOLOGICAL PROCEDURES; POLARIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SURVIVAL RATE;

EID: 84955559232     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/2640746     Document Type: Article

References (39)

1. A. Kaser, S. Zeissig, and R. S. Blumberg, "Infammatory bowel disease, " Annual Review of Immunology, vol. 28, pp. 573-621, 2010.
2. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, "A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, " Gastroenterology, vol. 98, no. 3, pp. 694-702, 1990.
3. K. F. Nolan, V. Strong, D. Soler et al., "IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate infammatory gene products in response to danger signals, " Journal of Immunology, vol. 172, no. 4, pp. 2201-2209, 2004.
4. B. E. Berndt, M. Zhang, G.-H. Chen, G. B. Hufnagle, and J. Y. Kao, "The role of dendritic cells in the development of acute dextran sulfate sodium colitis, " Journal of Immunology, vol. 179, no. 9, pp. 6255-6262, 2007.
5. A. J. Friedenstein, U. F. Deriglasova, N. N. Kulagina et al., "Precursors for fbroblasts in diferent populations of hematopoietic cells as detected by the in vitro colony assay method, " Experimental Hematology, vol. 2, no. 2, pp. 83-92, 1974.
6. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
7. V. Volarevic, A. Al-Qahtani, N. Arsenijevic, S. Pajovic, and M. L. Lukic, "Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis, " Autoimmunity, vol. 43, no. 4, pp. 255-263, 2010.
8. V. Volarevic, B. Ljujic, P. Stojkovic, A. Lukic, N. Arsenijevic, and M. Stojkovic, "Human stem cell research and regenerative medicine-present and future, " British Medical Bulletin, vol. 99, no. 1, pp. 155-168, 2011.
9. V. Volarevic, S. Erceg, S. S. Bhattacharya, P. Stojkovic, P. Horner, and M. Stojkovic, "Stem cell-based therapy for spinal cord injury, " Cell Transplantation, vol. 22, no. 8, pp. 1309-1323, 2013.
10. D. Garcia-Olmo, M. Garcia-Arranz, and D. Herreros, "Expanded adipose-derived stem cells for the treatment of complex perianal fstula including Crohn's disease, " Expert Opinion on Biological Terapy, vol. 8, no. 9, pp. 1417-1423, 2008.
11. Y. Hayashi, S. Tsuji, M. Tsujii et al., "The transdiferentiation of bone-marrow-derived cells in colonic mucosal regeneration afer dextran-sulfate-sodium-induced colitis in mice, " Pharmacology, vol. 80, no. 4, pp. 193-199, 2007.
12. H. Tanaka, Y. Arimura, T. Yabana et al., "Myogenic lineage diferentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat, " Journal of Gastroenterology, vol. 46, no. 2, pp. 143-152, 2011.
13. F. Tanaka, K. Tominaga, M. Ochi et al., "Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-infammatory action in damaged tissue in rats, " Life Sciences, vol. 83, no. 23-24, pp. 771-779, 2008.
14. C. Wang, J. Chen, L. Sun, and Y. Liu, "TGF-? signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation, " Molecular Biology Reports, vol. 41, no. 8, pp. 4977-4983, 2014.
15. W. Liu, S. Zhang, S. Gu, L. Sang, and C. Dai, "Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through TGF?1, " Cellular Physiology and Biochemistry, vol. 35, no. 3, pp. 858-865, 2015.
16. M. Sioud, A. Mobergslien, A. Boudabous, and Y. Fløisand, "Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation, " Scandinavian Journal of Immunology, vol. 71, no. 4, pp. 267-274, 2010.
17. G. Radosavljevic, V. Volarevic, I. Jovanovic et al., "The roles of Galectin-3 in autoimmunity and tumor progression, " Immuno-logic Research, vol. 52, no. 1-2, pp. 100-110, 2012.
18. D. K. Hsu, R.-Y. Yang, Z. Pan et al., "Targeted disruption of the galectin-3 gene results in attenuated peritoneal infammatory responses, " The American Journal of Pathology, vol. 156, no. 3, pp. 1073-1083, 2000.
19. M. Duijvestein, M. E. Wildenberg, M. M. Welling et al., "Pre-treatment with interferon-? enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis, " Stem Cells, vol. 29, no. 10, pp. 1549-1558, 2011.
20. N. Demotte, R. Bigirimana, G. Wiëers et al., "A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infltrating lymphocytes, " Clinical Cancer Research, vol. 20, no. 7, pp. 1823-1833, 2014.
21. S. N. S. Murthy, H. S. Cooper, H. Shim, R. S. Shah, S. A. Ibrahim, and D. J. Sedergran, "Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin, " Digestive Diseases and Sciences, vol. 38, no. 9, pp. 1722-1734, 1993.
22. G. Whittem, A. Williams, and C. Williams, "Murine colitis modeling using dextran sulfate sodium, " Journal of Visualized Experiments, vol. 35, p. 1652, 2010.
23. F. Obermeier, G.Kojouharof, W.Hans, J. Schölmerich, V. Gross, and W. Falk, "Interferon-gamma (IFN-?)-and tumour necrosis factor (TNF)-induced nitric oxide as toxic efector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice, " Clinical and Experimental Immunology, vol. 116, no. 2, pp. 238-245, 1999.
24. V. Volarevic, B. S. Markovic, S. Bojic et al., "Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury, " European Journal of Immunology, vol. 45, no. 2, pp. 531-543, 2015.
25. F. Scheifele and I. J. Fuss, "Induction of TNBS colitis in mice, " Current Protocols in Immunology, chapter 15, unit 15.19, 2002.
26. I. Prigione, F. Benvenuto, P. Bocca, L. Battistini, A. Uccelli, and V. Pistoia, "Reciprocal interactions between human mesenchy-mal stem cells and gammadelta T cells or invariant natural killer T cells, " STEM CELLS, vol. 27, no. 3, pp. 693-702, 2009.
27. C. Bauer, P. Duewell, C. Mayer et al., "Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 infammasome, " Gut, vol. 59, no. 9, pp. 1192-1199, 2010.
28. W. Strober, I. J. Fuss, and R. S. Blumberg, "The immunology of mucosal models of infammation, " Annual Review of Immunology, vol. 20, pp. 495-549, 2002.
29. C. F. Krieglstein, W. H. Cerwinka, F. S. Laroux et al., "Regulation of murine intestinal infammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide, " The Journal of Experimental Medicine, vol. 194, no. 9, pp. 1207-1218, 2001.
30. J. Kim and P. Hematti, "Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages, " Experimental Hematology, vol. 37, no. 12, pp. 1445-1453, 2009.
31. A. J. Cutler, V. Limbani, J. Girdlestone, and C. V. Navarrete, "Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation, " Journal of Immunology, vol. 185, no. 11, pp. 6617-6623, 2010.
32. Q.-Z. Zhang, W.-R. Su, S.-H. Shi et al., "Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing, " Stem Cells, vol. 28, no. 10, pp. 1856-1868, 2010.
33. Y. Li, M. Komai-Koma, D. S. Gilchrist et al., "Galectin-3 is a negative regulator of lipopolysaccharide-mediated infammation, " Journal of Immunology, vol. 181, no. 4, pp. 2781-2789, 2008.
34. S.-B. Jeon, H. J. Yoon, C. Y. Chang, H. S. Koh, S.-H. Jeon, and E. J. Park, "Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway, " The Journal of Immunology, vol. 185, no. 11, pp. 7037-7046, 2010.
35. R. D. Stout, C. Jiang, B. Matta, I. Tietzel, S. K. Watkins, and J. Suttles, "Macrophages sequentially change their functional phenotype in response to changes in microenvironmental infuences, " The Journal of Immunology, vol. 175, no. 1, pp. 342-349, 2005.
36. V. Volarevic, M. Milovanovic, B. Ljujic et al., "Galectin-3 defciency prevents concanavalin A-induced hepatitis in mice, " Hepatology, vol. 55, no. 6, pp. 1954-1964, 2012.
37. E. P. K. Mensah-Brown, Z. Al Rabesi, A. Shahin et al., "Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice, " Clinical Immunology, vol. 130, no. 1, pp. 83-88, 2009.
38. P. G. Traber, H. Chou, E. Zomer et al., "Regression of fbrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease, " PLoS ONE, vol. 8, no. 10, Article ID e75361, 2013.
39. P. G. Traber and E. Zomer, "Terapy of experimental NASH and fbrosis with galectin inhibitors, " PLoS ONE, vol. 8, no. 12, Article ID e83481, 2013.